Literature DB >> 32420798

ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.

Yang Li1, An Jiang2.   

Abstract

BACKGROUND: Deemed as a member of malignant tumors, hepatocellular carcinoma (HCC) has been characterized as a lethal disease with high morbidity and mortality. It has been widely accepted that long noncoding RNAs (lncRNAs) play a big part in the complicated biologic processes of cancer. AIM OF THE STUDY: The purpose of the study is to figure out the role and molecular regulation mechanism of ST8SIA6-AS1 in HCC.
METHODS: The role of ST8SIA6-AS1 in HCC was validated by RT-qPCR, colony formation, ki-67 detection, TUNEL, JC-1 detection, wound healing and transwell-invasion assays, furthermore, the binding ability between ST8SIA6-AS1/HOXB6 and miR-5195-3p were confirmed by RNA pull down and luciferase reporter assays. Besides, the regulatory mechanism of ST8SIA6-AS1 to HOXB6/miR-5195-3p was measured by RT-qPCR and western blot assays.
RESULTS: We measured that ST8SIA6-AS1 was highly expressed in HCC cell lines. Then knockdown of it suppressed cell proliferation, migration and migration but activated cell apoptosis in HCC. Furthermore, ST8SIA6-AS1 could bind with miR-5195-3p and negatively regulated its expression in HCC. Subsequently, it confirmed that HOXB6 was target gene of miR-5195-3p and positively modulated by ST8SIA6-AS1 in HCC. Finally, we verified that miR-5195-3p deficiency or HOXB6 upregulation countervailed the repressing effects of ST8SIA6-AS1 depletion on HCC progression.
CONCLUSIONS: To sum up, ST8SIA6-AS1 promotes HCC progression by absorbing miR-5195-3p to regulate HOXB6, which might provide some worthy suggestions to research the development process of HCC.

Entities:  

Keywords:  HOXB6; ST8SIA6-AS1; hepatocellular carcinoma; miR-5195-3p

Year:  2020        PMID: 32420798      PMCID: PMC7515456          DOI: 10.1080/15384047.2020.1743150

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  21 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.

Authors:  Bhawna Rastogi; Amit Kumar; Satish K Raut; Naresh K Panda; Vidya Rattan; Nainesh Joshi; Madhu Khullar
Journal:  Cancer Invest       Date:  2017-03-07       Impact factor: 2.176

Review 3.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

4.  MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4.

Authors:  Bingpeng Chen; Jingjing Liu; Ji Qu; Yang Song; Yuxiang Li; Su Pan
Journal:  Tumour Biol       Date:  2017-07

Review 5.  MicroRNA and cancer--a brief overview.

Authors:  Mario Acunzo; Giulia Romano; Dorothee Wernicke; Carlo M Croce
Journal:  Adv Biol Regul       Date:  2014-09-28

6.  Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus.

Authors:  Massimiliano di Pietro; Pierre Lao-Sirieix; Shelagh Boyle; Andy Cassidy; Dani Castillo; Amel Saadi; Ragnhild Eskeland; Rebecca C Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-17       Impact factor: 11.205

7.  lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.

Authors:  Changjie Jiao; Zhiming Song; Jianming Chen; Jing Zhong; Weibin Cai; Suke Tian; Songlin Chen; Yunfeng Yi; Yun Xiao
Journal:  Oncol Rep       Date:  2016-09-22       Impact factor: 3.906

8.  Report of incidence and mortality in China cancer registries, 2009.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Guanglin Li; Lingyou Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

9.  Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.

Authors:  Yun Cui; Fuming Zhang; Chunkai Zhu; Liang Geng; Tongde Tian; Huaimin Liu
Journal:  Oncotarget       Date:  2017-03-14

10.  A Kelch domain-containing KLHDC7B and a long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer cell proliferation via the interferon signaling pathway.

Authors:  Gookjoo Jeong; Hansol Bae; Dawoon Jeong; Juyeon Ham; Sungbin Park; Hyeon Woo Kim; Han-Sung Kang; Sun Jung Kim
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

View more
  9 in total

1.  ST8SIA6-AS1 Promotes the Epithelial-to-Mesenchymal Transition and Angiogenesis of Pituitary Adenoma.

Authors:  Zuowei Li; Chengcheng Zhang; Xin Zong; Zhao Wang; Rong Ren; Lei Wang; Ping Sun; Chunmei Zhu; Mingxia Guo; Guizhen Guo; Guo Hu; Ya'nan Wu
Journal:  J Oncol       Date:  2022-06-22       Impact factor: 4.501

2.  CD105 expression is associated with invasive capacity in ovarian cancer and promotes invasiveness by inhibiting NDRG1 and regulating the epithelial-mesenchymal transition.

Authors:  Jin Zhang; Xiubo Sang; Rui Zhang; Jingjing Chi; Wenpei Bai
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy.

Authors:  Weichen Wang; Longlong Wang; Mengyue Yang; Chunwei Wu; Rui Lan; Weiwei Wang; Yuze Li
Journal:  Cell Death Dis       Date:  2021-11-10       Impact factor: 8.469

4.  MicroRNA-5195-3p alleviates high glucose‑induced injury in human ARPE-19 cells by targeting GMFB.

Authors:  Jingjing Liu; Yongsheng Hou; Lili Lin; Nannan Yu; Yanyan Zhang
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

5.  Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma.

Authors:  Chuanli Zeng; Gang Yuan; Yaoren Hu; Donghui Wang; Xiaojun Shi; Dedong Zhu; Airong Hu; Yina Meng; Jialin Lu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  MiR-5195-3p functions as a tumor suppressor in prostate cancer via targeting CCNL1.

Authors:  Xing Zeng; Zhiquan Hu; Yuanqing Shen; Xian Wei; Jiahua Gan; Zheng Liu
Journal:  Cell Mol Biol Lett       Date:  2022-03-08       Impact factor: 5.787

Review 7.  SurviveAI: Long Term Survival Prediction of Cancer Patients Based on Somatic RNA-Seq Expression.

Authors:  Omri Nayshool; Nitzan Kol; Elisheva Javaski; Ninette Amariglio; Gideon Rechavi
Journal:  Cancer Inform       Date:  2022-10-07

8.  LncRNA SNHG11 aggravates cell proliferation and migration in triple-negative breast cancer via sponging miR-2355-5p and targeting CBX5.

Authors:  Lei Yu; Wei Zhang; Peng Wang; Qi Zhang; Aihua Cong; Xiuyuan Yang; Kai Sang
Journal:  Exp Ther Med       Date:  2021-06-18       Impact factor: 2.447

9.  LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis.

Authors:  Junchuang He; Hongxian Yan; Sidong Wei; Guoyong Chen
Journal:  Onco Targets Ther       Date:  2021-05-17       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.